Literature DB >> 8401505

No imprinting involved in the expression of DM-kinase mRNAs in mouse and human tissues.

G Jansen1, M Bartolomei, V Kalscheuer, G Merkx, N Wormskamp, E Mariman, D Smeets, H H Ropers, B Wieringa.   

Abstract

To explain the restriction of early onset cases of myotonic dystrophy (DM) to maternal transmittance and the significant excess of male transmitters in the last asymptomatic generation, the involvement of parental effects on the autosomal dominant mode of inheritance has been suggested. Using FISH we confirmed that the DM-kinase gene is proximal to the ApoE gene on mouse chromosome 7, close to an imprinted segment. To study whether there is any firm molecular basis for the speculation that imprinting may be involved in DM we have analysed the expression of paternal and maternal alleles of the DM-kinase gene in human and mouse tissues. Length polymorphisms in the 3' non coding exons of human and mouse DM kinase genes, i.e. the variable [CTG]n repeat motif in humans and a newly identified Cn stretch variation in mice, served as tools to distinguish between allelic RNA products in various tissues. In human tissues, presence of transcripts from both parental alleles could be demonstrated by RT-PCR. In mouse, similar observations were made using a RNAse protection assay on fetal and adult muscle RNAs. We conclude that imprinting does not play a role in the expression of the DM kinase gene.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8401505     DOI: 10.1093/hmg/2.8.1221

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  8 in total

1.  The DMPK gene of severely affected myotonic dystrophy patients is hypermethylated proximal to the largely expanded CTG repeat.

Authors:  P Steinbach; D Gläser; W Vogel; M Wolf; S Schwemmle
Journal:  Am J Hum Genet       Date:  1998-02       Impact factor: 11.025

Review 2.  Dynamic mutations on the move.

Authors:  G R Sutherland; R I Richards
Journal:  J Med Genet       Date:  1993-12       Impact factor: 6.318

3.  Changes in myotonic dystrophy protein kinase levels and muscle development in congenital myotonic dystrophy.

Authors:  Denis Furling; Le Thanh Lam; Onnik Agbulut; Gillian S Butler-Browne; Glenn E Morris
Journal:  Am J Pathol       Date:  2003-03       Impact factor: 4.307

4.  Influence of sex of the transmitting parent as well as of parental allele size on the CTG expansion in myotonic dystrophy (DM).

Authors:  H G Brunner; H T Brüggenwirth; W Nillesen; G Jansen; B C Hamel; R L Hoppe; C E de Die; C J Höweler; B A van Oost; B Wieringa
Journal:  Am J Hum Genet       Date:  1993-11       Impact factor: 11.025

5.  Genome Therapy of Myotonic Dystrophy Type 1 iPS Cells for Development of Autologous Stem Cell Therapy.

Authors:  Yuanzheng Gao; Xiuming Guo; Katherine Santostefano; Yanlin Wang; Tammy Reid; Desmond Zeng; Naohiro Terada; Tetsuo Ashizawa; Guangbin Xia
Journal:  Mol Ther       Date:  2016-05-12       Impact factor: 11.454

6.  Normal variation at the myotonic dystrophy locus in global human populations.

Authors:  C Zerylnick; A Torroni; S L Sherman; S T Warren
Journal:  Am J Hum Genet       Date:  1995-01       Impact factor: 11.025

7.  A case of paternally inherited congenital myotonic dystrophy.

Authors:  M Nakagawa; H Yamada; I Higuchi; Y Kaminishi; T Miki; K Johnson; M Osame
Journal:  J Med Genet       Date:  1994-05       Impact factor: 6.318

8.  Characteristics of intergenerational contractions of the CTG repeat in myotonic dystrophy.

Authors:  T Ashizawa; M Anvret; M Baiget; J M Barceló; H Brunner; A M Cobo; B Dallapiccola; R G Fenwick; U Grandell; H Harley
Journal:  Am J Hum Genet       Date:  1994-03       Impact factor: 11.025

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.